26-A-14486-ACC CARDIOVASCULAR OUTCOMES OF GLP-1 RECEPTOR AGONISTS ADDED TO SGLT2 INHIBITORS VERSUS SGLT2 INHIBITORS ALONE IN TYPE 2 DIABETES MELLITUS: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS
20260 citationsJournal Article
Field-Weighted Citation Impact: 0.00
26-A-14486-ACC CARDIOVASCULAR OUTCOMES OF GLP-1 RECEPTOR AGONISTS ADDED TO SGLT2 INHIBITORS VERSUS SGLT2 INHIBITORS ALONE IN TYPE 2 DIABETES MELLITUS: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS | Researchclopedia